Michael Yaffe Laboratory, Articles 1–20 Michael YAFFE, David H.

Michael Yaffe Laboratory, He is also a co-founder and a member of the scientific advisory board of Applied Biomath and Thrombo-Therapeutics, and a clinical advisor to Cardiff Oncology. edu M. A founder of Consensus Pharmaceuticals, the DNA Repair Company, and Merrimack Pharmaceuticals, Professor Yaffe is also the Chief Scientific Editor of Science Signaling. Yaffe studies the chain of reactions that controls a cell’s response to stress, cell injury, and DNA damage. , Charité — University Medicine Berlin, 2016. The Yaffe Lab is interested in understanding how signaling pathways are integrated at the molecular and systems level to control cellular responses. His laboratory studied cell growth and subcellular structure, with particular focus on mitochondria, the cellular power plants. edu Articles 1–20 Michael YAFFE, David H. Research in the Yaffe lab continues to focus on how cell signaling events determine the response of cells to DNA damage and mitotic stress, and how these types of cell stress influence the innate immune microenvironment within tissues and tumors. Our interest has particularly focused on signaling pathways and networks that control cell cycle progression and DNA damage responses in cancer and cancer therapy, as well as the cross-talk between inflammation, cytokine signaling and cancer The Yaffe Lab Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology 77 Massachusetts Avenue, 76-353 Cambridge, MA 02139 Accessibility Nov 2, 2016 · Media SOLUTIONS with/in/sight: Masterclass with Michael Yaffe KochInstituteMIT Solutions with/in/sight: Masterclass with Michael Yaffe, November 2, 2016 Links Search PubMed for Yaffe Lab publications Michael Yaffe Professor of Biology & Biological Engineering, MIT Verified email at mit. The Yaffe lab is particularly interested in: (1) signaling pathways and networks that control cell cycle progression and DNA damage responses in cancer and cancer therapy; and (2) cross-talk between inflammation, cytokine signaling and cancer. Yaffe is a co-founder of Consensus Pharmaceuticals, the DNA Repair Company, On-Q-ity, and Merrimack Pharmaceuticals. D. Koch Professor | Cited by 41,587 | of Massachusetts Institute of Technology, MA (MIT) | Read 482 publications | Contact Michael YAFFE Feb 1, 2018 · Michael Yaffe heads the MIT Center for Precision Cancer Medicine February 1, 2018 | MIT News Current lab members Alexander Bungert Visiting Scientist bungerta@mit. Michael B. Michael is a Professor Emeritus and was on the faculty for 23 years at the University of California, San Diego (UCSD). Our goal is to understand how signaling pathways are integrated at the molecular and systems levels to control cellular responses. ul0, p0zodq, zda, cxb2q, whn4sr, 0of, tvzpu, hjau5j, iit, pwb,